XCell-Center Presents Impressive Results from Cerebral Palsy Stem Cell Treatment
March 8, 2010
Dusseldorf, Germany, (PRWEB) March 8, 2010 -- The XCell-Center
has released impressive results from a follow-up study of 100
cerebral palsy patients treated with autologous bone marrow stem
cells. Overall, 67% improved following treatment.
This improvement rate is consistent with the rate released in
September 2009 for 45 cerebral palsy patients and provides further
support to the premise that patients with cerebral palsy can be
treated safely and effectively with autologous stem cell
therapy.
The most common improvement, reported over 70% of the time, was a
decrease in arm and hand spasticity. 60% of patients experienced
improvements in hand and finger motor skills, coordination, and
general use.
"Griffin underwent his first stem cell treatment at the
XCell-Center in April 2009. Cognitive improvements materialized
after about 3 weeks and physical improvements started at 3 - 6
months. Griffin's muscle tone improved along with his attention
span and ability to engage others. He no longer required Botox
which he needed twice before stem cell therapy," said Carol
Wayland, the mother of Griffin Perez, a patient who continues to
improve after his second stem cell treatment in September,
2009.
Griffin's full story can be read online here:
/patient-stories/cerebral-palsy/griffin-perez.aspx
Leg and foot coordination improved in nearly half of the patients.
Approximately 50% had reduced lower limb spasticity. Over 40% were
able to walk better.
Speech improved in almost 60% of patients. 1 in 5 showed improved
cognition.
"Since they include many more patients with greater levels of
individual improvement, these new results are even more encouraging
to us than those released for 45 cerebral palsy patients in 2009.
We are now looking forward to seeing results for our newly
developed neuro-endoscopic autologous stem cell implantation
technique (NEASCI™) which we expect to deliver even more impressive
results than these," stated Dr. Ute Tamaschke, the
XCell-Center's pediatric neurosurgeon. NEASCI results are
anticipated to be released in 2011.
Interested parties may visit the XCell-Center website to view the
complete results:
/treatments/results/cerebral-palsy.aspx
Each treatment begins by collecting a small amount bone marrow from
the patient's hip via thin needle mini-puncture. The stem cells are
separated from the bone marrow at the XCell-Center's EU certified
cGMP laboratory, where they are counted and their vitality is
confirmed. The last step consists of inserting a fine spinal needle
between the patient's L4 and L5 vertebrae and injecting the stem
cells into the cerebrospinal fluid which flows into the brain. The
cost for this cerebral palsy treatment is 9,000 Euros.
NEASCI™ treatments start at 17,800 Euros.
About the XCell-Center
The XCell-Center operates treatment centers in Cologne and
Dusseldorf, Germany. It is the first clinic in Europe to specialize
in regenerative medicine using autologous bone marrow stem cell
therapy and operates in accordance with German law, European
guidelines and ISO 9001. Its specialized medical team of German
physicians includes specialists in: neurosurgery, orthopedics,
cardiology, radiology, anesthesiology and pharmacology.
The XCell-Center also treats
Diabetes and its complications (Erectile Dysfunction and
Peripheral Artery Disease),
Stroke,
Cerebral Palsy,
Autism,
Spinal Cord Injuries,
Orthopedic diseases,
Heart Disease and degenerative diseases such as
Multiple Sclerosis,
Parkinson's,
Alzheimer's and several
eye diseases.
Since its inauguration in 2007, the XCell-Center has treated more
than 2,500 patients.
For safety data please visit:
/media/89867/safety%20database%20lp%20febr2010.pdf
For more information on Stem Cell Therapy:
XCell-Center Website:
XCell-Center GmbH
at the Institute for Regenerative Medicine
Am Heerdter Krankenhaus 2
40549 Dusseldorf, Germamy
E-Mail: info@xcell-center.de
Phone: 1-866-680-8202 (USA Toll-Free) (+49) 0221-802-5095
(Germany)
Fax: 1-713-583-9322 (USA) (+49) 0221-2921-2550 (Germany)
